SLC5A2 and type 2 diabetes mellitus: Arterial stiffness is a cardiovascular risk factor, frequently found inpatients with T2DM, and associated with the occurrence of cardiovascular events.SGLT2 inhibitors have been shown in multiple clinical trials to improve arterialstiffness and vascular resistance by reducing blood pressure [74].